Clinical trials
Terminated Observational Carcinoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Azienda USL Reggio Emilia - IRCCS | 1 |
| Jason Hafron | 1 |
| Lexent Bio, Inc. | 1 |
| National Institute on Deafness and Other Communication Disorders (NIDCD) | 1 |
| University of Florida | 1 |
| University of Southern California | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma | 6 |
| Carcinoma, Renal Cell | 2 |
| Neoplasms | 2 |
| Colorectal Neoplasms | 1 |
| Ischemia | 1 |
| Liver Neoplasms | 1 |
| Renal Insufficiency | 1 |
| Sarcoma | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.